US EditionChina defends fentanyl controls in white paper, rejects US claims as ‘lies’
- China released a white paper detailing its actions in controlling fentanyl-related substances and its cooperation efforts with other countries, including the US, stating its commitment to drug control as a responsible major power.
- The Chinese government stated that the fentanyl issue in the US originates internally and is not attributed to China, emphasizing their strict prohibition of drugs.
- China added 46 new psychoactive substances to its controlled substances list and engaged in anti-drug cooperation with the US, which has been recognized by US government departments.
- A Chinese spokesperson criticized the US for using the fentanyl issue to justify tariffs on Chinese imports and advocated for consultations based on equality and mutual respect.
Insights by Ground AI
Does this summary seem wrong?
14 Articles
14 Articles
All
Left
4
Center
1
Right
1
The white paper renders the 'fentanyl lie' self-defeating: Global Times editorial
Shifting the responsibility for domestic governance failures onto others and abusing tariffs as a means of pressure and coercion will not cure America’s ills, nor will it help Washington achieve its political objectives.
·Beijing, China
Read Full Article
Root cause of fentanyl issue in U.S. itself, China points out in response to smears
A Chinese spokesperson on Tuesday told the United States that the Chinese people have never been swayed by fallacies, deterred by intimidation or cowed by bullying.Pressuring, coercing or issuing threats is not the right way to engage with China, and
·Beijing, China
Read Full Article
Coverage Details
Total News Sources14
Leaning Left4Leaning Right1Center1Last UpdatedBias Distribution67% Left
Bias Distribution
- 67% of the sources lean Left
67% Left
L 67%
C 17%
R 17%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
